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Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease caused by the selective 
death of motor neurons. Approximately 5–10% of patients have a genetically inherited form known as 
familial ALS (FALS). Approximately 15–20% of FALS cases are associated with missense mutations or 
small deletions in the gene that encodes SOD1 (Aoki et al., 1993; Rosen et al., 1993). Transgenic (Tg) 
mice that carry mutant SOD1 genes provided an animal model that has helped elucidate how mutations in 
the SOD1 gene cause motor neuron death (Gurney et al., 1994; Murakami et al., 2007). Although the 
underlying mechanism of ALS has not yet been fully clarified, several reports have implicated the 
involvement of oxidative stress in the selective death of motor neurons in both ALS patients and animal 
models (Abe, 2007; Barber and Shaw, 2010; Barnham et al., 2004; Miyazaki et al., 2009; Robberecht, 
2000; Warita et al., 2001). 
We previously showed blood flow-metabolism uncoupling in the affected spinal cords from the 
pre-symptomatic stage ALS model mice, suggesting relative spinal cord hypoxia (Miyazaki et al., 2011a). 
We also showed a selective lack of vascular endothelial growth factor (VEGF) induction in motor 
neurons (MNs) after hypoxic exposure in SOD1-Tg ALS model mice (Ilieva et al., 2003; Murakami et al., 
2003). Other studies have suggested that the lack of VEGF induction is linked to the degeneration of 
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motor neurons in ALS (Cleveland and Rothstein, 2001; Ischiropoulos and Beckman, 2003; Lambrechts et 
al., 2003). Under hypoxic conditions, VEGF is activated by hypoxia inducible factor (HIF-1), which 
consists of a heterodimer of two basic helix-loop-helix PAS (Per-ARNT-Sim) proteins, HIF-1α and 
HIF-1β. HIF-1α accumulates in response to hypoxia, whereas HIF-1β is constitutively expressed. Thus, 
HIF1-α serves as an important mediator of the hypoxic response and upregulates important angiogenic 
factors, such as VEGF and VEGF receptor 1 (Sharp and Bernaudin, 2004). While HIF-1α expression is 
increased in the spinal cord of ALS model mice (Xu et al., 2011), the combination of HIF-1α and 
downstream proteins, such as heme oxygenase-1 (HO-1) and erythropoietin (EPO), as well as VEGF, 
have not been studied in ALS.  
In the present study, we examined temporal and spatial changes in HIF-1α, VEGF, HO-1, and 
EPO over the course of motor neuron degeneration in the spinal cord of ALS model mice. 




Immunohistochemical analyses of hypoxic sensor proteins HIF-1α, VEGF, HO-1, 
and EPO 
Nissl staining showed no change in the number of large motor neurons (MNs) in the lumbar 
spinal anterior horn at 10, 14 and 18W in WT mice (Fig. 1 Aa). Tg mice showed a progressive loss of 
large MNs from 14 to 18W (Fig. 1 Ac, d), with a progressive increase in the number of surrounding small 
glial cells (Fig. 1 A, c, d). 
In the spinal cord of WT mice, HIF-1α was slightly detected in the cytoplasm of anterior large 
MNs and surrounding small glial cells at 10-18W (Fig. 1 Ae). In Tg mice, HIF-1α staining strength and 
intracellular localization progressively accumulated in the MNs of Tg mice, especially at 18W (Fig. 1 A 
f-h, arrowheads). HIF-1α staining in the surrounding glial cells of Tg mice also progressively 
accumulated at 18W (Fig. 1 Ag-h, arrows). 
VEGF immunoreactivity was slightly detected in both the cytoplasm of anterior large MNs and 
surrounding small glial cells in WT mice at 10-18W (Fig. 1 Ai). In the spinal cord of Tg mice, VEGF 
staining strength and intracellular localization did not change in large MNs at 10-18W (Fig. 1 A, j-l, 
arrowheads), but VEGF staining progressively accumulated in the surrounding glial cells of Tg mice, 
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especially at 18W (Fig. 1 Ak-l, arrows). 
HO-1 immunoreactivity was also detected in the cytoplasm of anterior large MNs and 
surrounding small glial cells in WT mice at 10-18W (Fig. 1 Am). In the spinal cord of Tg mice, HO-1 
staining strength and intracellular localization did not change in MNs at 10-18W (Fig. 1 An-p, 
arrowheads), whereas it progressively accumulated in the surrounding glial cells of Tg mice, especially at 
18W (Fig. 1 Ap, arrows). 
Finally, EPO immunoreactivity was detected mainly in the cytoplasm of anterior large MNs 
and surrounding small glial cells in WT mice at 10-18W (Fig. 1 Am). In the spinal cord of Tg mice, EPO 
staining strength and intracellular localization did not change in MNs at 10-18W (Fig. 1 A, q-s, 
arrowheads). In contrast, the ratio of EPO-positive glia-like cells was decreased, especially at 18W (Fig. 1 
At, arrows). 
Accounting for the different number of anterior large MNs and glia-like cells, the relative 
ratios of the number of VEGF-, HO-1-, and EPO-positive to Nissl-stained cells showed no significant 
changes at 10-14W in large MNs (Fig. 1 Bv-1, w-1, x-1); only HIF-1α showed a significant increase at 18 
W in Tg mice (0.55±0.10, **p < 0.01 vs. WT, ##p < 0.01 vs. 10W Tg, Fig. 1 Bu-1). In contrast, the 
relative ratio of the number of HIF-1α-positive to Nissl-stained surrounding glial cells was significantly 
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increased at 14W (0.51 ± 0.06, *p < 0.05 vs. WT, #p < 0.05 vs. 10W Tg, Fig. 1 Bu-2) and 18W in Tg 
mice (0.74 ± 0.03, **p < 0.01 vs. WT, ##p < 0.01 vs. 10W Tg, Fig. 1 Bu-2). The ratio of VEGF positive 
surrounding glial cells was significantly increased at 18W in Tg mice (0.69 ± 0.04, *p < 0.05 vs. WT, #p 
< 0.05 vs. 10W Tg, Fig. 1 Bv-2), as was the ratio of HO-1-positive surrounding glial cells at 14W (0.65 ± 
0.08, *p < 0.05 vs. WT, Fig. 1 Bw-2) and 18W in Tg mice (0.82 ± 0.09, *p < 0.05 vs. WT, #p < 0.05 vs. 
10W Tg, Fig. 1 Bw-2). In contrast, the ratio of EPO-positive glial cells significantly reduced at 18W of 
Tg mice (0.35 ± 0.04, *p < 0.05 vs. WT , Fig. 1 Bx-2). 
 
Double immunofluorescence analysis 
In the spinal cord of WT mice, HIF-1α was detected mainly in the cytoplasm of anterior large 
MNs (Fig. 2 A, WT, red). In the spinal cord of Tg mice, the intracellular localization of HIF-1α did not 
change at 10-18W in anterior large MNs (Fig. 2 A, Tg, red). HIF-1α plus neurofilament double-positive 
cells were found both in WT and 10-18W Tg in large MNs (Fig. 2 A, bottom). 
In astroglial cells, HIF-1α plus GFAP double-positive cells were not detected in the spinal cord 
of WT mice (Fig. 2 B, WT, Merge). In the Tg mice, HIF-1α plus GFAP double-positive cells showed a 
progressively increased intensity at 10-18W in Tg mice (Fig. 2 B, bottom). 
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In microglial cells, HIF-1α plus Iba-1 double-positive cells were not detected in the spinal cord 
of WT mice (Fig. 2 C, WT, Merge), whereas HIF-1α plus Iba-1 double-positive cells became evident at 
14-18W in the spinal cord of Tg mice (Fig. 2 C, bottom). 
 
Western blot analyses of hypoxic sensor proteins HIF-1α, VEGF, HO-1, and EPO 
Western blot analysis showed that HIF-1α protein levels in WT mice did not change 
significantly with age at 10-18W (Fig. 3, white bars), but Tg mice showed a progressive increase in the 
HIF-1α protein ratio relative to β-tubulin: 0.19 ± 0.06 at 10W (Fig. 3, gray bar), 0.28 ± 0.02 at 14W (*p < 
0.05 vs. 14W WT, Fig. 3, dark bar), and 0.49 ± 0.06 at 18 W (**p < 0.01 vs. 18W WT, ##p < 0.01 vs. 
10W Tg, §p < 0.05 vs. 14W Tg, Fig. 3, black bar). 
VEGF protein levels in WT mice did not change significantly with age at 10-18W by Western 
blot analysis (Fig. 4, white bars). Tg mice also did not show any significant change in VEGF protein 
levels relative to β-tubulin: 0.41 ± 0.05 at 10W, 0.41 ± 0.06 at 14W, and 0.50 ± 0.08 at 18 W (Fig. 4, gray, 
dark, and black bars). 
The third Western blot analysis showed that HO-1 protein levels in WT mice did not change 
significantly with age at 10-18W (Fig. 5, white bars). However, Tg mice showed a remarkable increase in 
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HO-1 protein levels relative to β-tubulin at 18W: 0.36 ± 0.07 (**p < 0.01 vs. 18W WT, ##p < 0.01 vs. 
10W Tg, Fig. 5, black bars) compared to 0.11 ± 0.02 at 10W, 0.12 ± 0.02 at 14W. 
The fourth Western blot analysis showed that EPO protein levels in WT mice did not change 
significantly with age at 10-18W (Fig. 6, white bars). Tg mice also did not show any significant change in 
protein levels relative to β-tubulin: 0.99 ± 0.15 at 10W, 0.82 ± 0.10 at 14W, and 0.82± 0.12 at 18 W (Fig. 
6, gray, dark, and black bars). 




The present study investigated the presence of and changes to hypoxic stress sensor proteins 
regulated by the protein HIF-1α in the lumbar anterior horn of ALS model mice. The results demonstrated 
progressive increases in HIF-1α protein expression both in the anterior large MNs and surrounding glial 
cells in Tg mice from 14W, with significant breaks in the glial cells between early symptomatic 14W and 
end stage 18W (Fig. 1 Ag-h, Bu, and Fig. 3). Double immunofluorescence analyses revealed that HIF-1α 
plus GFAP and Iba-1 double-positive surrounding glial cells showed progressively increased intensity at 
10-18W (Fig. 2 B, C). Expression of VEGF and HO-1 also showed a progressive increase but were 
significant only in the surrounding glial cells at 18W (Fig. 1 Aj-l, n-p, Bv, w); however, Western blot 
analyses only showed a significant increase at 18W in HO-1 but not VEGF (Fig. 4, 5). In contrast, EPO 
protein expression was decreased in the surrounding glial cells of Tg mice at 18W (Fig. 1 At, Bx-2). This 
is the first report demonstrating the induction of the hypoxic stress sensor protein HIF-1α with 
downstream protein expression alterations in VEGF, HO-1 and EPO. 
We recently demonstrated that ALS model mice possessed a damaged oxidative stress sensor 
system with Kelch-like ECH-associated protein 1 (Keap1)/nuclear erythroid 2-related factor 2 (Nrf2) 
expressed in the anterior large MNs (Mimoto et al., 2012). Another report showed the activation of Nrf2 
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in spinal cord motor neurons in ALS model mice when protected by ethylamine (Neymotin et al., 2011). 
Our previous reports that showed the selective lack of vascular endothelial growth factor (VEGF) 
induction in MNs after hypoxic exposure in ALS model mice (Ilieva et al., 2003; Murakami et al., 2003), 
as well as other studies of chronic hypoxia (Cleveland and Rothstein, 2001; Ischiropoulos and Beckman, 
2003; Lambrechts et al., 2003). All of these findings indicate that both oxidative and hypoxic stresses 
may be important pathogenic mechanisms in ALS. 
Hypoxia triggers a series of alterations in neuronal events, such as membrane dysfunction and 
depolarization, metabolic decline, signal transduction deficiency, and abnormal cell morphology (Chao 
and Xia, 2010); it also affects the expression of hypoxic stress sensor proteins. HIF-1 plays a central role 
in cellular adaption to hypoxia by transcriptionally upregulating its target genes, which are involved in 
angiogenesis, erythropoiesis, and glicolysis, in addition to other processes (Tanaka and Nangaku, 2009). 
HIF-1 consists of α and β subunits and mainly exists as a heterodimer with multiple effects (Ebert et al., 
1995), including dilatation of blood vessels by inducing nitric oxide synthetase and HO-1 (Semenza, 
1998) and promotion of angiogenesis via VEGF induction (Ebert et al., 1995). We have shown blood 
flow-metabolism uncoupling and decreased spinal blood flow in the affected spinal anterior gray matter 
from the pre-symptomatic stage in these mice. We suggested that this early and progressive 
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flow-metabolism uncoupling could be profoundly involved in the entire disease process as a vascular 
component of ALS pathology, suggesting a relative hypoxia in the spinal cord (Miyazaki et al., 2011a). 
In our previous study, HIF-1α was strongly induced in the ischemic core and penumbra with a 
peak at 2 hours after transient middle cerebral artery occlusion (Zhang et al., 2010). The present study 
demonstrated a progressive increase in HIF-1α protein expression both in the anterior large MNs and 
surrounding glial cells of Tg mice from 14 to 18W (Fig. 1 Ag-h, Bu, and Fig. 3). HO-1 and VEGF were 
also increased in the surrounding glial cells of Tg mice at 18W (Fig. 1 Aj-l, n-p, Bv-2, w-2). Conversely, 
EPO was significantly decreased in the surrounding glial cells of Tg mice at 18W (Fig. 1 At, Bx-2). 
These findings support previous studies showing the increase of HIF-1α (Xu et al., 2011) and VEGF 
(Murakami et al., 2003) protein levels in G93A Tg mice. However, the time point of VEGF protein 
increase was late compared to that of HIF-1. A previous study showed VEGF mRNA was 
down-regulated in the spinal cord of G93A Tg mice, and in the glial cells expressing mutant SOD1 (Lu et 
al., 2007). The temporal difference of HIF-1 and VEGF protein increase could be partly explained by 
VEGF dysregulation by the mutant SOD1. Several studies mentioned that exogenous VEGF was 
neuroprotective by activation of VEGF receptor and subsequent Akt signaling (Lunn et al., 2009; Zheng 
et al., 2004; Zheng et al., 2007). Therefore, the dysregulation of VEGF in the spinal cord of ALS mice 
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might be related to ALS progression. The HO-1 increase of Tg mice (Fig. 1 Bw-2) may also be related to 
Nrf2, because Nrf/antioxidant response element (ARE) pathway also regulates HO-1 protein levels 
(Mimoto et al., 2012). During hypoxia, EPO reduced neuronal cell death with glucose deprivation (Sinor 
and Greenberg, 2000). In the present study, however, EPO was not increased in the anterior large MNs of 
Tg mice but was decreased in the surrounding glial cells. A previous study also showed that EPO 
expression was increased not in the anterior horn but in unaffected areas including the brainstem nuclei of 
ALS model mice (Chung et al., 2004). A recent study demonstrated that the EPO level in cerebrospinal 
fluid was lower in ALS patients than in other neurodegenerative patients (Brettschneider et al., 2006).  
In summary, we found that the hypoxic sensor protein HIF-1α was induced more in the 
surrounding glial cells than in the most affected anterior large MNs. In addition, downstream proteins 
responded only in the surrounding glial cells at the late to end stages of ALS progression. These findings 
indicate that MNs profoundly lack the neuro-protective response of the HIF-1α system to hypoxic stress, 
which could be an important mechanism of neurodegeneration in ALS. 
 
MATERIALS AND METHODS 
Animal Model 
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All experimental procedures were carried out according to the guidelines of the Animal Care 
and Use Committee of the Graduate School of Medicine, Dentistry, and Pharmaceutical Science of 
Okayama University. A Transgenic (Tg) mouse line with the G93A human SOD1 mutation (G1H/1) was 
obtained from Jackson Laboratories (Bar Harbor, ME) and maintained as hemizygotes by mating Tg 
males with C57BL/6J females. The offspring were genotyped using a PCR assay with DNA obtained 
from tail tissue samples according to our previous methods (Miyazaki et al., 2011b; Morimoto et al., 
2009). G93A Tg mice show disease onset at roughly 14 weeks (W) of age and die approximately 3-4 
weeks later. Thus, we took 10, 14, and 18 W G93A male mice for the presymptomatic stage, early 
symptomatic stage, and end stage, respectively. We used age-matched non-Tg C57BL/6J male littermates 
(WT) as controls. 
 
Primary Antibodies 
For immunohistochemistry and/or Western blot analysis, the following primary antibodies 
were used: mouse anti-HIF-1α monoclonal antibody (Novus Biologicals, CO, USA), rabbit anti-VEGF 
polyclonal antibody (Abcam, MA, USA), rabbit anti-HO-1 polyclonal antibody (Enzo Life Science, NY, 
USA), rabbit anti-EPO polyclonal antibody (Santa Cruz, CA, USA), rabbit anti neurofilament polyclonal 
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antibody (Millipore, MA, USA), goat anti-GFAP monoclonal antibody (Millipore, MA, USA), goat 
anti-Iba-1 polyclonal antibody (Abcam, Cambridge, MA), and mouse anti-β-tubulin monoclonal antibody 
(Sigma, Tokyo, Japan). 
 
Immunohistochemical Analysis 
At 10, 14 or 18 W (n = 5 each), each mouse was deeply anesthetized with pentobarbital (40 mg/kg, 
i.p.) and transcardially perfused with heparinized saline followed by 4 % paraformaldehyde in 0.1 M 
phosphate buffer (pH 7.4). The lumbar spinal cord spanning L4-5 was removed and further fixed by 
immersion in the same fixative for 4 h and then frozen after cryoprotection with a series of 
phosphate-buffered sucrose solutions of increasing concentration (10, 20, and 30 %). Transverse sections 
of 10 µm thickness were cut through the lumbar cord on a cryostat. The sections were first incubated in 
0.3 % H2O2/methanol for 10 min to block endogenous peroxidase activity. The sections were then 
incubated with primary antibodies overnight at 4℃. After being washed in phosphate-buffered saline 
(PBS, pH 7.4), the sections were incubated with the appropriate biotinylated IgG (1:500; Invitrogen, 
Eugene, OR) for 1 h at room temperature. After being washed in PBS, the sections were incubated with 
ABC complex (Vector Laboratories, Burlingame, CA) for 30 min at room temperature and then 
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visualized with 3,3’-diaminobenzidine tetrahydrochloride (DAB). To confirm the specificity of the 
primary antibody, a set of sections was stained in a similar manner but without the primary antibodies. 
The dilutions of primary antibodies in this study were as follows: anti-HIF-1α (1:500), VEGF (1:200), 
HO-1 (1:200), and EPO (1:100).  
 
Cell Quantification 
For quantitative analysis, the sections from the same animal with immunohistochemical analysis 
were also stained with cresyl violet staining (Nissl stain), and all cells in the ventral horns, below a lateral 
line across the spinal cord from the central canal, were microscopically video-captured. The cells with a 
diameter greater than 20 µm with a clear nucleoli were quantified as anterior large MNs as described 
previously (Ohta et al., 2006), and the cells without Nissl were quantified as surrounding glial cells in the 
same manner. The immunopositive cells were compared with Nissl stain (large MNs and the surrounding 
glial cells, respectively). 
 
Double immunofluorescence analysis 
To determine the detailed spatial distribution of each protein, 10 µm lumbar sections were 
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incubated with a mixture of anti-HIF-1α (1:500) plus neurofilament (1:500), GFAP (1:500), or Iba-1 
(1:500) overnight at 4℃. After being rinsed in PBS, the sections were simultaneously incubated with two 
appropriate Alexa fluor-conjugated secondary antibodies (1:500; Invitro-gen) for 1 hr at room 
temperature. The sections were scanned using a confocal microscope equipped with argon and HeNe1 
lasers (LSM-510; Zeiss, Jena, Germany). 
 
Western blot analysis 
With each set of animals (n = 5 each), each mouse at 10, 14 or 18 W was deeply anesthetized 
with pentobarbital (40 mg/kg, i.p.) and decapitated. The lumbar spinal cord was removed. The lumbar 
cord samples were sonicated in ice-cold lysis buffer containing 50 mM Tris-HCl (pH 7.2), 250 mM NaCl, 
1 % NP-40, and Complete Mini Protease Inhibitor Cocktail (Roche, Basel, Switzerland). The lysate was 
centrifuged at 12,000 g for 10 min at 4℃, the supernatant was collected, and the protein concentration 
was determined by the Lowry assay (Bio-Rad, Hercules, CA, USA). Twenty micrograms of the total 
protein extract was loaded onto a 12.5 % polyacrylamide gel, separated by sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis, and transferred to a polyvinylidene fluoride membrane 
(Millipore, MA, USA). After being washed with PBS containing 5 % skim milk and 0.2 % Tween 20, the 
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membranes were incubated with primary antibody overnight at 4℃. After being washed with PBS, the 
membranes were probed with an appropriate horseradish peroxidase-conjugated secondary antibody 
(Amersham Biosciences, Buckinghamshire, UK), and immunodetection was performed with an enhanced 
chemiluminescent substrate (Pierce, Rockford, IL). After the ECL detection, the membranes were 
incubated in stripping buffer (62.5 mM Tris-HCl, pH 6.7; 2 % SDS; 0.7 % β-mercaptoethanol) at 50℃ 
for 15 min and then re-probed with a monoclonal anti-β-tubulin antibody (1:5,000; Sigma, Tokyo, Japan) 
as a loading control for protein quantification. The signals were quantified with a luminoimage analyzer 
(LAS 1000-Mini; Fuji Film, Tokyo, Japan), and quantitative densitometric analysis was performed using 
Image J software. The dilutions of primary antibodies in this study were as follows: anti-HIF-1α (1:1,000), 
VEGF (1:1,000), HO-1 (1:1,000), EPO (1:1,000), β-tubulin (1:5,000) 
 
Statistical Analysis 
Significant differences in the Western blot and immunohistochemical analyses with DAB 
staining between the age-matched WT and Tg mice were evaluated using Welch’s t-test. Statistical 
significance was accepted at p < 0.05.  
  




This work was partly supported by the Grant-in-Aid for Scientific Research (B) 21390267 and the 
Ministry of Education, Science, Culture and Sports of Japan, Grants-in-Aid from the Research Committee 
of CNS Degenerative Diseases (Nakano I), and grants (Mizusawa H, Nishizawa M, Sasaki H) from the 





Abe, K., 2007. [Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis 
(ALS)]. Rinsho Shinkeigaku. 47, 790-4. 
Aoki, M., Ogasawara, M., Matsubara, Y., Narisawa, K., Nakamura, S., Itoyama, Y., Abe, K., 
1993. Mild ALS in Japan associated with novel SOD mutation. Nat Genet. 5, 323-4. 
Barber, S.C., Shaw, P.J., 2010. Oxidative stress in ALS: key role in motor neuron injury and 
therapeutic target. Free Radic Biol Med. 48, 629-41. 
Barnham, K.J., Masters, C.L., Bush, A.I., 2004. Neurodegenerative diseases and oxidative 
stress. Nat Rev Drug Discov. 3, 205-14. 
Brettschneider, J., Widl, K., Ehrenreich, H., Riepe, M., Tumani, H., 2006. Erythropoietin in 
the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett. 404, 347-51. 
Chao, D., Xia, Y., 2010. Ionic storm in hypoxic/ischemic stress: can opioid receptors subside 
it? Prog Neurobiol. 90, 439-70. 
Chung, Y.H., Joo, K.M., Kim, Y.S., Lee, K.H., Lee, W.B., Cha, C.I., 2004. Enhanced 
expression of erythropoietin in the central nervous system of SOD1(G93A) 
transgenic mice. Brain Res. 1016, 272-80. 
HIF-1α and its downstream proteins in ALS model mice 
Sato, 19 
 
Cleveland, D.W., Rothstein, J.D., 2001. From Charcot to Lou Gehrig: deciphering selective 
motor neuron death in ALS. Nat Rev Neurosci. 2, 806-19. 
Ebert, B.L., Firth, J.D., Ratcliffe, P.J., 1995. Hypoxia and mitochondrial inhibitors regulate 
expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem. 
270, 29083-9. 
Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, 
J., Hentati, A., Kwon, Y.W., Deng, H.X., et al., 1994. Motor neuron degeneration in 
mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264, 
1772-5. 
Ilieva, H., Nagano, I., Murakami, T., Shiote, M., Shoji, M., Abe, K., 2003. Sustained 
induction of survival p-AKT and p-ERK signals after transient hypoxia in mice 
spinal cord with G93A mutant human SOD1 protein. J Neurol Sci. 215, 57-62. 
Ischiropoulos, H., Beckman, J.S., 2003. Oxidative stress and nitration in neurodegeneration: 
cause, effect, or association? J Clin Invest. 111, 163-9. 
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., 
Wyns, S., Thijs, V., Andersson, J., van Marion, I., Al-Chalabi, A., Bornes, S., Musson, 
R., Hansen, V., Beckman, L., Adolfsson, R., Pall, H.S., Prats, H., Vermeire, S., 
Rutgeerts, P., Katayama, S., Awata, T., Leigh, N., Lang-Lazdunski, L., Dewerchin, 
M., Shaw, C., Moons, L., Vlietinck, R., Morrison, K.E., Robberecht, W., Van 
Broeckhoven, C., Collen, D., Andersen, P.M., Carmeliet, P., 2003. VEGF is a 
modifier of amyotrophic lateral sclerosis in mice and humans and protects 
motoneurons against ischemic death. Nat Genet. 34, 383-94. 
Lu, L., Zheng, L., Viera, L., Suswam, E., Li, Y., Li, X., Estevez, A.G., King, P.H., 2007. 
Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis 
destabilizes vascular endothelial growth factor mRNA and downregulates its 
expression. J Neurosci. 27, 7929-38. 
Lunn, J.S., Sakowski, S.A., Kim, B., Rosenberg, A.A., Feldman, E.L., 2009. Vascular 
endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. 
Dev Neurobiol. 69, 871-84. 
Mimoto, T., Miyazaki, K., Morimoto, N., Kurata, T., Satoh, K., Ikeda, Y., Abe, K., 2012. 
Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein 
responses in the motor neuron of ALS model mice. Brain Res. 
Miyazaki, K., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., Abe, K., 2009. 
HIF-1α and its downstream proteins in ALS model mice 
Sato, 20 
 
Spinal anterior horn has the capacity to self-regenerate in amyotrophic lateral 
sclerosis model mice. J Neurosci Res. 87, 3639-48. 
Miyazaki, K., Masamoto, K., Morimoto, N., Kurata, T., Mimoto, T., Obata, T., Kanno, I., Abe, 
K., 2011a. Early and progressive impairment of spinal blood flow-glucose 
metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb 
Blood Flow Metab. 
Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., 
Matsuura, T., Abe, K., 2011b. Disruption of neurovascular unit prior to motor 
neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res. 89, 718-28. 
Morimoto, N., Nagai, M., Miyazaki, K., Kurata, T., Takehisa, Y., Ikeda, Y., Kamiya, T., 
Okazawa, H., Abe, K., 2009. Progressive decrease in the level of YAPdeltaCs, 
prosurvival isoforms of YAP, in the spinal cord of transgenic mouse carrying a 
mutant SOD1 gene. J Neurosci Res. 87, 928-36. 
Murakami, T., Ilieva, H., Shiote, M., Nagata, T., Nagano, I., Shoji, M., Abe, K., 2003. 
Hypoxic induction of vascular endothelial growth factor is selectively impaired in 
mice carrying the mutant SOD1 gene. Brain Res. 989, 231-7. 
Murakami, T., Nagai, M., Miyazaki, K., Morimoto, N., Ohta, Y., Kurata, T., Takehisa, Y., 
Kamiya, T., Abe, K., 2007. Early decrease of mitochondrial DNA repair enzymes in 
spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 
gene. Brain Res. 1150, 182-9. 
Neymotin, A., Calingasan, N.Y., Wille, E., Naseri, N., Petri, S., Damiano, M., Liby, K.T., 
Risingsong, R., Sporn, M., Beal, M.F., Kiaei, M., 2011. Neuroprotective effect of 
Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse 
model of amyotrophic lateral sclerosis. Free Radic Biol Med. 51, 88-96. 
Ohta, Y., Nagai, M., Nagata, T., Murakami, T., Nagano, I., Narai, H., Kurata, T., Shiote, M., 
Shoji, M., Abe, K., 2006. Intrathecal injection of epidermal growth factor and 
fibroblast growth factor 2 promotes proliferation of neural precursor cells in the 
spinal cords of mice with mutant human SOD1 gene. J Neurosci Res. 84, 980-92. 
Robberecht, W., 2000. Oxidative stress in amyotrophic lateral sclerosis. J Neurol. 247 Suppl 
1, I1-6. 
Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, 
D., Goto, J., O'Regan, J.P., Deng, H.X., et al., 1993. Mutations in Cu/Zn superoxide 
dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 




Semenza, G.L., 1998. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr 
Opin Genet Dev. 8, 588-94. 
Sharp, F.R., Bernaudin, M., 2004. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci. 
5, 437-48. 
Sinor, A.D., Greenberg, D.A., 2000. Erythropoietin protects cultured cortical neurons, but 
not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett. 290, 213-5. 
Tanaka, T., Nangaku, M., 2009. Drug discovery for overcoming chronic kidney disease 
(CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a 
novel therapeutic approach in CKD. J Pharmacol Sci. 109, 24-31. 
Warita, H., Hayashi, T., Murakami, T., Manabe, Y., Abe, K., 2001. Oxidative damage to 
mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Brain Res Mol 
Brain Res. 89, 147-52. 
Xu, R., Wu, C., Zhang, X., Zhang, Q., Yang, Y., Yi, J., Yang, R., Tao, Y., 2011. Linking 
hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res. 
1372, 133-44. 
Zhang, X., Deguchi, K., Yamashita, T., Ohta, Y., Shang, J., Tian, F., Liu, N., Panin, V.L., 
Ikeda, Y., Matsuura, T., Abe, K., 2010. Temporal and spatial differences of multiple 
protein expression in the ischemic penumbra after transient MCAO in rats. Brain 
Res. 1343, 143-52. 
Zheng, C., Nennesmo, I., Fadeel, B., Henter, J.I., 2004. Vascular endothelial growth factor 
prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 56, 564-7. 
Zheng, C., Skold, M.K., Li, J., Nennesmo, I., Fadeel, B., Henter, J.I., 2007. VEGF reduces 
astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. 
Biochem Biophys Res Commun. 363, 989-93. 
 
 




Fig. 1 - A. Nissl staining (Aa-d) and immunohistochemistry for HIF-1α (Ae-h), VEGF (Ai-l), HO-1 
(Am-p) and EPO (Aq-t) in the anterior spinal cord of wild type (WT, 18 weeks (W)) and G93A 
transgenic (Tg) mice at 10, 14, and 18 W. Arrowheads and arrows indicate the anterior large MNs 
and the surrounding glial cells, respectively, with positive protein accumulation. Scale bar = 50 µm.  
B. Quantitative analysis of HIF-1α-, VEGF-, HO-1-, and EPO-positive MNs (Bu-1, v-1, w-1, x-1) 
and glial cells (Bu-2, v-2, w-2, x-2) in the anterior halves relative to the number of MNs and 
surrounding glial cells, respectively. The values are expressed as means ± SD. *p < 0.05, **p < 0.01 
vs. 18W WT, ##p < 0.05, #p < 0.05 vs. 10W Tg. 
Note that expression of HIF-1α showed a progressive increase both in the anterior large MNs and 
surrounding glial cells in Tg mice from 14 to 18W (Af-h, Bu). The expression levels of VEGF and HO-1 
also showed progressive increases but were significant only in the surrounding glial cells at 18W (Aj-l, 
n-p, Bv-2, w-2), while EPO was decreased in the surrounding glial cells of Tg mice at 18W (At, Bx-2). 
 
Fig. 2 - Double immunofluorescent analysis showing HIF-1α plus neurofilament (A), HIF-1α plus 
GFAP (B), and HIF-1α plus Iba-1 (C) in the anterior spinal cord of wild type (WT, 18W) and G93A 
Tg mice at 10, 14, and 18 W. Scale bars = 20 µm. Note that HIF-1α plus GFAP and Iba-1 
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double-positive surrounding glial cells showed progressive intensities at 10-18W (B, C). 
 
Fig. 3 - Western blot analysis of HIF-1α in the lumber spinal cord of WT and Tg mice at 10, 14, and 
18W (WT: n = 5 each; Tg: n = 5 each). Integrated density values expressed as ratios of the levels of 
HIF-1α to β-tubulin. The values are expressed as means ± SD. **p < 0.01 vs. 18W WT, #p < 0.05, 
##p < 0.01 vs. 10W Tg, §p < 0.05 vs. 14W Tg. 
 
Fig. 4 - Western blot analysis of VEGF in the lumber spinal cord of WT and Tg mice at 10, 14, and 
18W (WT: n = 5 each; Tg: n = 5 each). Integrated density values expressed as ratios of the levels of 
VEGF to β-tubulin. The values are expressed as means ± SD. 
 
Fig. 5 - Western blot analysis of HO-1 in the lumber spinal cord of WT and Tg mice at 10, 14, and 
18W (WT: n = 5 each; Tg: n = 5 each). Integrated density values expressed as ratios of the levels of 
HO-1 to β-tubulin. The values are expressed as means ± SD. **p < 0.01 vs. 18W WT, ##p < 0.01 vs. 
10W Tg. 
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Fig. 6 - Western blot analysis of EPO in the lumber spinal cord of WT and Tg mice at 10, 14, and 
18W (WT: n = 5 each; Tg: n = 5 each). Integrated density values expressed as ratios of the levels of 
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